PDCD1 and neoplasm: Recent research efforts aimed at comprehensively characterizing Tex subsets predictive of immunotherapy resistance have identified the PD1+CD38hiCD8+ T cell subset, highly abundant in both peripheral blood and tumor tissue of patients resistant to ICB therapy (17).